Review
Copyright ©The Author(s) 2025.
World J Hepatol. Aug 27, 2025; 17(8): 108772
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.108772
Figure 2
Figure 2 Intervention in the management of non-alcoholic fatty liver disease. The figure highlights various therapeutic interventions aimed at restoring gut and liver health, including dietary modifications incorporating antioxidants and hepatoprotective nutrients, microbiome-targeted approaches using probiotics and postbiotics like short-chain fatty acids, and the use of essential metal, Selenium. These strategies collectively help in enhancing gut integrity, reducing inflammation, and improving metabolic outcomes. SCFA: Short-chain fatty acid; IL-6: Interleukin-6; IL-1β: Interleukin-1β.